This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Piras, G Articles by Brady, J N Search for Related Content PubMed PubMed Citation Articles by Piras, G Articles by Brady, J N

 Previous Article  |  Next Article 

J Virol. 1994 October; 68(10): 6170-6179

Transcription of the human T-cell lymphotropic virus type I promoter by an alpha-amanitin-resistant polymerase.

Laboratory of Molecular Virology, National Cancer Institute, Bethesda, Maryland 20892.

ABSTRACT

The human T-lymphotropic virus type I (HTLV-I) promoter contains the structural features of a typical RNA polymerase II (pol II) template. The promoter contains a TATA box 30 bp upstream of the transcription initiation site and binding sites for several pol II transcription factors, and long poly(A)+ RNA is synthesized from the integrated HTLV-I proviral DNA in vivo. Consistent with these characteristics, HTLV-I transcription activity was reconstituted in vitro by using TATA-binding protein, TFIIA, recombinant TFIIB, TFIIE, and TFIIF, TFIIH, and pol II. Transcription of the HTLV-I promoter in the reconstituted system requires RNA pol II. In HeLa whole cell extracts, however, the HTLV-I long terminal repeat also contains an overlapping transcription unit (OTU). HTLV-I OTU transcription is initiated at the same nucleotide site as the RNA isolated from the HTLV-I-infected cell line MT-2 but was not inhibited by the presence of alpha-amanitin at concentrations which inhibited the adenovirus major late pol II promoter (6 micrograms/ml). HTLV-I transcription was inhibited when higher concentrations of alpha-amanitin (60 micrograms/ml) were used, in the range of a typical pol III promoter (VA-I). Neutralization and depletion experiments with three distinct pol II antibodies demonstrate that RNA pol II is not required for HTLV-I OTU transcription. Antibodies to basal transcription factors TATA-binding protein and TFIIB, but not TFIIIC, inhibited HTLV-I OTU transcription. These observations suggest that the HTLV-I long terminal repeat contains overlapping promoters, a typical pol II promoter and a unique pol III promoter which requires a distinct set of transcription factors.

This article has been cited by other articles:

• Perl, A., Colombo, E., Samoilova, E., Butler, M. C., Banki, K. (2000). Human Transaldolase-associated Repetitive Elements Are Transcribed by RNA Polymerase III. J. Biol. Chem. 275: 7261-7272 [Abstract] [Full Text]  
• Pessler, F., Hernandez, N. (1998). The HIV-1 Inducer of Short Transcripts Activates the Synthesis of 5,6-Dichloro-1-beta -D-benzimidazole-resistant Short Transcripts in Vitro. J. Biol. Chem. 273: 5375-5384 [Abstract] [Full Text]  
• Trejo, S. R., Fahl, W. E., Ratner, L. (1997). The Tax Protein of Human T-cell Leukemia Virus Type 1 Mediates the Transactivation of the c-sis/Platelet-derived Growth Factor-B Promoter through Interactions with the Zinc Finger Transcription Factors Sp1 and NGFI-A/Egr-1. J. Biol. Chem. 272: 27411-27421 [Abstract] [Full Text]  
• Piras, G., Dittmer, J., Radonovich, M. F., Brady, J. N. (1996). Human T-cell Leukemia Virus Type I Tax Protein Transactivates RNA Polymerase III Promoter in Vitro and in Vivo. J. Biol. Chem. 271: 20501-20506 [Abstract] [Full Text]